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Transplantation of bone marrow cells leads to engraftment of osteopoietic and hematopoietic progenitors. We
sought to determine whether the recently described transient expansion of the host osteoblastic niche after
marrow radioablation promotes engraftment of both osteopoietic and hematopoietic progenitor cells. Mice
infused with marrow cells 24 hours after total body irradiation (TBI) demonstrated signiﬁcantly greater
osteopoietic and hematopoietic progenitor chimerism than did mice infused at 30 minutes or 6 hours.
Irradiated mice with a lead shield over 1 hind limb showed greater hematopoietic chimerism in the irradiated
limb than in the shielded limb at both the 6- and 24-hour intervals. By contrast, the osteopoietic chimerism
was essentially equal in the 2 limbs at each of these intervals, although it signiﬁcantly increased when cells
were infused 24 hours compared with 6 hours after TBI. Similarly, the number of donor phenotypic long-term
hematopoietic stem cells was equivalent in the irradiated and shielded limbs after each irradiation-to-
infusion interval but was signiﬁcantly increased at the 24-hour interval. Our ﬁndings indicate that
a 24-hour delay in marrow cell infusion after TBI facilitates expansion of the endosteal osteoblastic niche,
leading to enhanced osteopoietic and hematopoietic engraftment.
 2013 Published by Elsevier Inc. on behalf of American Society for Blood and Marrow Transplantation.INTRODUCTION
Transplantation of heterogeneous populations of bone
marrow cells into radioablated hosts leads to engraftment of
rare hematopoietic stem cells (HSCs) in the appropriate
marrow niches in animalmodels and, presumably, in humans
[1,2]. We [3-8] and others [9-12] have shown that trans-
plantation of these marrow cells also leads to engraftment
and differentiation of donor osteopoietic stem/progenitor
cells. Osteopoietic donor chimerism is robust early after
transplantation but decreases over time [7]. Nonetheless, the
transplantable cells that give rise to osteopoiesis are capable
of expansion in primary recipients and of engraftment and
differentiation in secondary recipients, consistent with stem
cellelike behavior [7].
Hematopoietic cells initially engraft at discrete sites in the
epiphysis and metaphysis after bone marrow transplantation
(BMT) [13-15], whereas donor-derived osteopoiesis invariably
mirrors the locales of donor hematopoietic engraftment [7,13].
This suggests common niches for both regenerating activities,
although direct support for this hypothesis is lacking.edgments on page 1572.
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13.07.025Our observation that osteoblastic niches expand rapidly
after marrow radioablation [13] led us to consider that the
proliferating osteoblasts may support osteopoietic differenti-
ation of the transplanted marrow cells. Here we report
that transient expansion of host osteoblastic niches after
marrow radioablation fosters the engraftment and differen-
tiation of donor osteoprogenitors and that primitive hema-
topoietic progenitors engraft more readily in this expanded
microenvironment. In this murine model, a 24-hour interval
between radioablation and infusion of marrow cells
facilitated engraftment of both osteopoietic and hematopoi-
etic progenitors.
METHODS
Irradiation and BMT
Six- to 8-week-old FVB/N mice (Jackson Laboratory, Bar Harbor, ME)
were given a lethal dose (1125 cGy, single dose) of total body irradiation
(TBI) with a 137Cs source (Gammacell 40 Exactor Irradiator; Nordion, Ottawa,
Ontario, Canada) and were then transplanted with bone marrow cells ob-
tained from 6- to 8-week-old enhanced green ﬂuorescent protein (eGFP)
transgenic FVB/N mice [7,16]. To study mice irradiated with single-leg
shielding, we anesthetized the animals with a combination of ketamine
(100 mg/kg i.p.) and xylazine (10 mg/kg i.p.), and then immobilized them on
a ﬂat support surface. The left hind limbwas inserted into an apparatus with
3-cm lead plates blocking all radiation to that limb. At 30 minutes or at 6 or
24 hours after irradiation, the mice were injected with 2  106 eGFPþ
transgenic bone marrow cells. Unless otherwise noted, they were killed
3 weeks post-transplantation for ﬂow cytometric analysis and/or immu-
nohistochemical analysis. For ﬂow cytometric analysis of hematopoietic
stem/progenitor cells, marrow cells were obtained from the femoralerican Society for Blood and Marrow Transplantation.
R. Marino et al. / Biol Blood Marrow Transplant 19 (2013) 1566e1573 1567metaphyses. All animal protocols were approved by the Institutional Animal
Care and Use Committees at the participating institutions.
Immunohistochemical Staining and Microscopy
Tissue processing and immunohistochemical staining for GFP to identify
donor-derived bone cells were performed as previously described [13].
Brieﬂy, bones were ﬁxed in formalin and then decalciﬁed with Regu-
larCalImmuno (BBC Biochemical Corporation, Mount Vernon, WA) and
embedded in parafﬁn. Sections 6 mm thick were deparafﬁnized, rehydrated,
and treated with Chondroitinase ABC solution (.35 IU/mL; Sigma-Aldrich, St.
Louis, MO) at room temperature for 40 minutes for antigen retrieval.
Sections were blocked with .1 M maleic buffer (Sigma-Aldrich) containing
.15 M NaCl (Sigma-Aldrich), 2% blocking reagent (Roche Diagnostics GmbH,
Mannheim, Germany), and 20% FCS (Gemini Bio-Products, West Sacra-
mento, CA). Endogenous avidin and biotin were quenched using the Avidin/
Biotin Blocking Kit (Vector Laboratories, Burlingame, CA). Sections were
then incubated with rabbit anti-GFP antibody (1:250, Invitrogen, Carlsbad,
CA) at 4C overnight.
The following day, sections were incubated with biotinylated goat anti-
rabbit antibody (1:200, Vector Laboratories) at room temperature for 1 hour
followed by incubation for an hour with VECTASTAIN Elite ABC Reagent
(Vector Laboratories). Color was developed using the NovaRED Substrate Kit
(Vector Laboratories). The osteoblasts were identiﬁed as the large, cuboidal
cells with eccentrically placed nuclei along the endosteal surface. Osteocytes
were identiﬁed as single, often stellate-shaped, cells within the lacunae of
bone. GFPþ osteoblasts and osteocytes were enumerated using an AxioI-
mager.A1 microscope equipped with an AxioCam HRc digital camera (Carl
Zeiss MicroImaging, Inc., Thornwood, NY) by 2 investigators who were
blinded to the experimental conditions.
Osteopoietic chimerismwas determined as the percentage of GFPþ bone
cells in the epiphysis and metaphysis sampling a minimum of 200 cells per
histologic section. The mean of 3 sections was taken as the chimerism for
1 animal. In an effort to eliminate experimental bias, we assessed osteo-
poietic chimerism throughout these studies with themicroscopic evaluation
of immunostained histologic sections because it is the most precise method
to assess GFPþ bone cells [17] and eliminates sampling errors.
Flow Cytometry
Bone marrow cells from the epiphysis and metaphysis of each femur
were stained with the following antibodies: APC-conjugated anti-CD48,
APC-Alexa Fluor 750 conjugated anti-c-Kit, PE-conjugated anti-CD150,
PE-Cy5.5 conjugated anti-Sca-1 (eBioscience, San Diego, CA), and PE-Cy7
conjugated anti-Lineage (ie, CD4, CD8, CD11 b, Gr-1, B220, and Ter119; BD0.5 6 24 48
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Figure 1. Kinetics of osteoblast proliferation and osteopoietic/hematopoietic chime
(right) after TBI depicting the proliferation of the endosteal osteoblasts (arrows). (B)
Proliferation index as described in the text. Data points represent mean  standard de
the fraction of GFPþ osteoblasts and osteocytes in the metaphysis and epiphysis, de
Chimerism within the KLS subpopulation of marrow cells according to the intervals fr
marrow isolated from transplanted mice. (E) Bone chimerism, determined as in (C
deviation values.Biosciences, San Jose, CA). Flow cytometric analyses were performed on
a FACSAria (BD Biosciences). Analysis of recipient marrow cells was
restricted to the epiphysis and metaphysis of each femur because this is
a site of early hematopoietic marrow engraftment [13-15] and osteopoietic
engraftment [7,13].
Statistical Methods
All data are presented as means  standard deviations. Statistical
comparisons with a 2-tailed Student’s t-test or with a 1-way analysis of
variance with Tukey’s multiple comparison test were considered signiﬁcant
if the differences attained P  .05. All analyses were performed with Prism
software, version 4 (GraphPad Inc., San Diego, CA). To quantify the expan-
sion of osteoblastic niches, we relied on a proliferation index based on the
number of osteoblast layers along the endosteal surface: 1 ¼ a single layer,
2 ¼ 2 layers, 3 ¼ 3 layers, and 4 ¼ 4 or more layers.
RESULTS
Transplanted Donor Osteoprogenitors Engraft Within the
Expanding Population of Endosteal Osteoblasts
We previously reported that the magnitude of donor-
derived osteopoiesis is greatest early after BMT and
decreases over the ensuing months [7]. Recognizing the
abundance of endosteal osteoblasts comprising the niche
expansion observed 48 hours after marrow radioablation
[13], we reasoned that the transiently proliferating endosteal
osteoblasts may create a permissive environment for osteo-
poietic differentiation. To begin to investigate mechanisms of
donor osteoprogenitor engraftment, we assessed the kinetics
of endosteal osteoblast proliferation during the ﬁrst 72 hours
after TBI (Figure 1A) using a proliferation index in which
1 represents a single layer of osteoblasts along the endosteal
surface, 2 represents 2 layers, 3 represents 3 layers, and
4 represents 4 or more layers. Six hours after TBI, endosteal
osteoblasts appeared mostly as a single layer. However,
48 hours after TBI, endosteal osteoblasts were more often
observed in 3 or more layers (Figure 1A). The population of
endosteal osteoblasts achieved the greatest observed rate of
increase at 3 to 24 hours postirradiation (average rate, .0806 24 48
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maximal proliferation was attained. The rate then slowed
(average rate, .014 units/hour) as the population of endosteal
osteoblasts expanded to its maximum by 48 hours after TBI
and then was stable at 72 hours (Figure 1B). Using BrdU and
Ki-67 double-labeling experiments, we previously demon-
strated that this expansion of the endosteal osteoblast pop-
ulation is due to proliferation of resident osteoblasts [18]. To
determine if osteopoietic or hematopoietic engraftment was
associated with the proliferative state of the endosteal
osteoblasts, we transplanted bone marrow cells harvested
from a transgenic GFP donor into lethally irradiated FVB/N
mice at graded time intervals, from 30 minutes to 48 hours,
after irradiation (5 mice per group). Three weeks after
transplantation, the mice were killed and the femora were
analyzed by immunohistochemical staining for donor (GFPþ)
osteopoietic engraftment.
Marrow cells transplanted 30 minutes after TBI generated
only 12.0%  2.0% osteopoietic engraftment (Figure 1C),
similar to the result when marrow was infused 6 hours after
TBI (13.0%  2.7%). By contrast, when marrow was infused
24 hours after irradiation, osteopoietic engraftment was
signiﬁcantly higher (20.0%  4.6% versus 12.0%  2.0%,
P ¼ .007); this ﬁnding was essentially unchanged at the
48-hour interval (17.0%  5.6%, P ¼ NS compared with
24 hours). There were no differences in the donor contri-
bution to the short-term engraftment of unfractionated bone
marrow, peripheral blood leukocytes, or Gr-1þ neutrophils
(data not shown); however, the c-Kitþ lineage Sca-1þ (KLS)
fraction of bone marrow, which represents primitive hema-
topoietic progenitors, showed signiﬁcantly greater donor
chimerism at this 3-week post-transplantation time point
when cells were infused 24 hours rather than 30 minutes
after irradiation (88.1%  8.1% versus 76.5%  6.2%, P ¼ .04;
Figure 1D).
We previously reported that the measured engraftment of
donor osteopoietic cells after transplantation is saturable,
indicating discrete engraftment sites [1]; that the endosteal
osteoblast expansion after TBI correlates with expansion of
cells characteristic of the stem cell niche [13] and with HSC
engraftment [18], and that the osteoblast expansion is readily
reversible after engraftment of transplanted hematopoietic
cells [13], which seems to be driven speciﬁcally by engraft-
ment of primitive hematopoietic progenitors [19]. Collectively,
these data led us to consider that submaximal engraftment of
transplantable osteopoietic progenitors may be associated
with a reduction in the number of engraftment sites.
To test this hypothesis, we infused 9 mice with 1  106
marrow cells 24 hours after TBI and another 9 with 3 daily
doses of 3.3  105 marrow cells (equal total cell dose in each
group), beginning 24 hours after irradiation. Over this 24- to
72-hour interval, the magnitude of the osteoblast expansion
remained stable (Figure 1B), suggesting the number of
engraftment sites is stable [13] and the osteopoietic chime-
rism resulting from these 2 infusion protocols is similar. In
contrast to this prediction, the osteopoietic chimerism
produced by a single dose of 1  106 cells was signiﬁcantly
greater than that seen after the 3-dose regimen (25%  8%
versus 16%  7%, P ¼ .04, Figure 1E). These data suggest that
the submaximal engraftment of donor osteoprogenitors after
the ﬁrst of the 3 doses may have down-regulated the total
number of engraftment sites, thereby reducing the number
of available sites for the transplantable osteoprogenitor and
diminishing the osteopoietic engraftment potential of the
2 subsequent marrow cell doses.Osteopoietic Engraftment without Direct Marrow
Radioablation
To test the hypothesis that proliferating host osteoblasts
are permissive for donor osteoprogenitor engraftment, we
irradiated mice using a lead shield over the left hind limb.
This enabled us to deliver 1125 cGy to the remainder of the
body, including the lymphoid organs (to prevent rejection of
the infused GFP-expressing cells), while the shielded hind
limb remained protected, providing an internal control for
assessing the effect of radioablation and niche expansion on
osteoprogenitor engraftment.
Infusion of bone marrow cells 6 hours after TBI led to
greater short-term donor chimerism in the irradiated leg
compared with the shielded leg, whether total marrow cells
(84%  3.6% versus 10%  2.6%, P < .001, n ¼ 10) or KLS cells
(71%  11.6% versus 3%  .9%, P < .001, n ¼ 10) (Figure 2A)
were analyzed. Unexpectedly, osteopoietic engraftment was
comparable in both hind legs (15%  4.0% versus 17%  1.5%)
at this interval (Figure 2A). Similar results were obtained
when the marrow cells were infused 24 hours after TBI
(Figure 2B). Control mice, which were irradiated without leg
shielding, showed similar hematopoietic and osteopoietic
chimerism values in the 2 legs when marrow was infused
either 6 or 24 hours after TBI (Figure 2C,D).
Early versus Late Marrow Transplantation
Our data indicate that transplanting marrow cells
24 hours after TBI leads to greater hematopoietic progenitor
and osteopoietic engraftment than cells transplanted after
a shorter interval (Figure 1), possibly because of
radioablation-induced expansion of host osteoblastic niches.
However, osteopoietic engraftment, in contrast to hemato-
poietic engraftment, seems to be similar with or without
marrow radioablation (Figure 2). In an effort to understand
this incongruity, we compared chimerism results for each
leg, irradiated and shielded, independently of the other.
When marrow was infused 24 hours after TBI, compared
with 6 hours, the irradiated leg displayed a signiﬁcant
decrease in both total marrow chimerism (84%  3.6% versus
40%  18.9%, P < .001) and hematopoietic progenitor (KLS
cell) chimerism (71%  11.6% versus 53%  19.1%, P ¼ .04)
(Figure 3A). Osteopoietic chimerism, by contrast, was clearly
greater in mice infused after the longer interval
(37.4%  12.9% versus 17.0%  1.5%, P ¼ .009, Figure 3A),
consistent with the notion that delay between TBI and
marrow infusion promotes host osteoblast proliferation,
thereby facilitating donor osteopoietic engraftment.
Comparison of data for the shielded leg at both intervals
revealed comparable total marrow chimerism values
(10.5%  2.6% versus 12.1%  3.1%), but, notably, the KLS
chimerism was 2-fold greater after marrow infusion at
24 hours (2.6%  .9% versus 5.3%  2.5%, P ¼ .04; Figure 3B).
Similar to results for the irradiated leg, osteopoietic chime-
rism was signiﬁcantly increased at the 24- compared with
the 6-hour interval (15.4%  3.9% versus 30.1%  12.1%,
P ¼ .02, Figure 3B).
HSC Engraftment
Engraftment of primitive osteoprogenitors is greater
when donor cells are infused 24 hours rather than 6 hours
after TBI, even when the marrow space is shielded from
radiation (Figure 3B). To address whether this relationship
extends to HSCs, we analyzed the engrafted hematopoietic
marrow cells for the surface phenotype of CD150þ CD48
CD41 (designated SLAM cells) after transplantation. First
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Figure 2. Comparison of osteopoietic and hematopoietic chimerism in irra-
diated versus shielded (nonirradiated) limbs according to time from TBI to
marrow infusion. Total marrow cell, KLS marrow cell, and bone chimerism
were determined in shielded versus irradiated legs 3 weeks post-
transplantation, when donor cells were transplanted at (A) 6 hours or (B)
24 hours. Histograms are representative of the ﬂow cytometric analyses for
the bone marrow and KLS chimerism in shielded (- - -) and unshielded (d)
legs. Total marrow cell and bone chimerism were determined in left and right
legs (both unshielded during irradiation) of control mice 3 weeks post-
transplantation, when donor cells were transplanted at (C) 6 hours or (D)
24 hours. In all graphs, bars represent the mean  standard deviation (n ¼ 10).
NS, not statistically signiﬁcant.
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Figure 3. Independent analysis of irradiated and shielded (nonirradiated)
limbs for osteopoietic and hematopoietic chimerism. Total marrow cell, KLS
marrow cell, and bone chimerism were assessed in the irradiated (A) and
shielded (nonirradiated) (B) legs of mice infused with donor cells 6 hours
versus 24 hours after TBI. These data are derived from the same experiment as
in Figure 2. Bars represent mean  standard deviation values. NS, not statis-
tically signiﬁcant.
R. Marino et al. / Biol Blood Marrow Transplant 19 (2013) 1566e1573 1569described by Kiel et al. [20], this phenotype distinguishes
a primitive hematopoietic population enriched for long-term
repopulating cells. In each experiment, mice were killed for
analysis 3 weeks after TBI. Marrow cellularity, assessed by
visual inspection of histologic sections, and the total number
of recovered cells were similar between the shielded and
irradiated limbs (data not shown).In mice transplanted 6 hours after TBI, the absolute
number of SLAM cells (identiﬁed by ﬂow cytometry) per 106
total marrow cells analyzed from the shielded leg was
signiﬁcantly greater than that from the irradiated leg
(246  86 versus 123  40, P ¼ .002; Figure 4A Top), but the
donor chimerism among SLAM cells was signiﬁcantly greater
in the irradiated leg (20%  8% versus 52%  16%, P < .001;
Figure 4A Middle). Unexpectedly, the absolute number of
donor-derived (GFPþ) SLAM cells in the 2 legs was similar
(46  23 versus 60  26, P ¼ NS; Figure 4A Bottom).
Similar relationships were noted between SLAM cells
from the shielded and irradiated legs of mice transplanted
24 hours after TBI (Figure 4B). Interestingly, both the irradi-
ated and the shielded legs of mice transplanted 24 hours
after TBI had signiﬁcantly more donor-derived (GFPþ) SLAM
cells than did the corresponding leg of mice transplanted
6 hours after irradiation (Figure 4C,D). Control mice, which
received TBI without shielding (both legs irradiated), had
equivalent absolute number of SLAM cells, SLAM chimerism,
and absolute number of donor SLAM cells in both legs, doc-
umenting the lack of preferential engraftment in our model
(data not shown).
Of interest, the overall number of SLAM cells per leg in the
control mice was 860  508, statistically indistinguishable
from the ﬁnding in the irradiated leg (804  264) but less
than that in the shielded leg (1480  720, P ¼ .04) of the
experimental mice. The chimerism in the control mice was
64.3%  8.2%, or 2-fold greater than results for the irradiated
(P < .001) and shielded (P < .001) legs. Moreover, the abso-
lute number of GFPþ SLAM cells was 444  264, greater than
ﬁndings in either the irradiated (P ¼ .05) or shielded legs
(P ¼ .04).
Osteoblast Niche Proliferation
In addition to the vital role of endosteal osteoblast ex-
pansion and marrow niche remodeling for HSC engraftment
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Figure 4. Engraftment of CD150þ CD48 CD41 (SLAM) cells in irradiated and
shielded (nonirradiated) limbs. SLAM cells were measured in the bone marrow
from the shielded or irradiated legs of mice transplanted at (A) 6 hours or (B)
24 hours after TBI and analyzed for chimerism and other engraftment
parameters. The absolute SLAM count represents the number of SLAM cells per
106 viable marrow cells as determined by ﬂow cytometry. Chimerism is the
percentage of donor-derived (GFPþ) SLAM cells. The absolute GFPþ SLAM
count represents the number of GFPþ SLAM cells per 106 viable marrow cells.
(C) Comparison of the absolute GFPþ SLAM count in the irradiated limb when
marrow was infused 6 hours versus 24 hours after TBI. (D) Comparison of the
absolute GFPþ SLAM count in the shielded (nonirradiated) limb when marrow
was infused 6 hours versus 24 hours after TBI. In all panels, bars represent the
mean  standard deviation values. NS, not statistically signiﬁcant.
R. Marino et al. / Biol Blood Marrow Transplant 19 (2013) 1566e15731570[13,18,21], we postulated that osteoblastic niche expansion
contributes to a permissive environment for osteoprogenitor
engraftment anddifferentiation aswell. To test this prediction
in a rigorous manner, it was necessary to quantify the
expansion of these niches.We therefore irradiatedmice using
our leg-shielding apparatus and then calculated the prolifer-
ation index as in Figure 1A,B.
Analysis of histologic sections of paired (shielded and
irradiated) femora taken 24 hours after irradiation demon-
strated substantial osteoblast proliferation in the irradiated
leg (3.16  .3; Figure 5A,E), which was signiﬁcantly greater
than in the shielded leg (1.43  .5, P < .001; Figure 5B,E), as
predicted by our previous study [13]. Although the prolifer-
ation index for osteoblasts in the shielded leg was low
(1.43  .5), it did signiﬁcantly exceed the index for nonirra-
diated controls (1.0  .0, n ¼ 8, P ¼ .03; Figure 5C,E). Inter-
estingly, the shielded leg of the irradiated mice exhibited
several areas of more cuboidal, or so-called plump, osteo-
blasts [22] (Figure 5D), which are commonly observed in the
endosteal niche of radioablated marrow (Figure 5A),
compared with the ﬂattened appearance of these cells at
homeostasis (Figure 5C), which one would expect in the
absence of radioablation.DISCUSSION
We previously reported donor-derived osteopoiesis after
BMT in childrenwith osteogenesis imperfecta [3], which was
associated with measurable clinical beneﬁt [4]. More
recently, BMT has been reported to effectively ameliorate the
osteogenesis imperfecta phenotype in a mouse model [12],
corroborating our clinical investigation. We also demon-
strated the osteopoietic differentiation potential of trans-
planted murine bone marrow cells [5,6]. Independent
conﬁrmation of this observation [9-12] has established the
osteopoietic capacity of heterogeneous populations of
transplanted marrow cells. Indeed, marrow cells hold
promise as cell therapy for an array of bone disorders [23].
Our current data show that delaying marrow infusion for
24 hours after TBI leads to a signiﬁcantly greater level of
osteopoietic engraftment than can be achieved with earlier
infusions. These ﬁndings suggest that transient expansion of
host osteoblastic niches [13], which, in our FVB/N murine
model, becomes near-maximal at 24 hours [17,18]
(Figure 1B), may be a critical regulator of donor osteopro-
genitor differentiation to osteoblasts.
Interestingly, 4-fold more HSCs, identiﬁed phenotypically
as CD150þ CD48 CD41 [20], were found in the mice at
3 weeks post-transplantation when marrow was infused at
24 hours, compared with 6 hours, after TBI. Delaying marrow
infusion after TBI has been shown to promote donor cell
engraftment, as measured by hematopoietic reconstitution,
andmay be superior to infusion immediately after TBI [24-26].
These studies have generally attributed improved hemato-
poietic reconstitution after delayed marrow cell infusion to
the partial clearance of proinﬂammatory cytokines that are
released in response to TBI-induced host tissue damage and
may be associated with the early events of graft-versus-host
disease [27,28] and possibly graft rejection. Our data provide
an intriguing alternative explanation: Transient expansion of
the endosteal niche after radioablation fosters engraftment of
both primitive hematopoietic cells and osteoprogenitors.
To assess the effect of radioablation-induced endosteal
niche proliferation in a rigorously controlled manner, we
shielded one hind limb during TBI to prevent niche expan-
sion in a deﬁned marrow region. As expected, the donor
chimerism among all marrow cells and hematopoietic
progenitors (KLS cells) was signiﬁcantly greater in the irra-
diated limb compared with the shielded limb. Surprisingly,
however, the percentages of osteopoietic chimerism in the
2 limbs did not differ appreciably, indicating that neither
direct exposure of the bone to ionizing radiation nor marrow
cell ablation is required for engraftment and differentiation
of transplantable marrow osteoprogenitor cells. We also
found it striking that the number of phenotypically deﬁned
donor HSCs (SLAM cells) was essentially identical in both
limbs. Thus, ablation of host marrow cells does not appear to
facilitate early engraftment of the transplanted donor HSCs.
Although this observation may seem counterintuitive and,
indeed, contradictory to the importance of osteoblast niche
expansion for HSC engraftment, it is in fact consistent with
our current understanding of stem cell niches and suggests
an especially important role of niche remodeling for HSC
engraftment.
Given that the 2 hind limbs (which in our experience
contain about 60  106 nucleated marrow cells) represent an
estimated 25% of the total marrow volume of a mouse [29],
the 2  106 nucleated cell transplant used in this study
accounted for less than 1% of the marrow cell compartment.
Because roughly the same fraction of niches (w1%) is
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Figure 5. Endosteal osteoblast proliferation in the irradiated versus shielded (nonirradiated) limbs. The photomicrographs depict H & E staining of femora taken from
mice 24 hours after TBI. (A) Femur section from an irradiated limb; arrows indicate osteoblasts. (B) Femur section from shielded limb depicting regions of prolif-
erating osteoblasts (multiple cell layers, left) and quiescent osteoblasts (single cell layer, right). (C) Femur section from a control (nonirradiated) mouse included for
comparison; arrows indicate osteoblasts. (D) Selected region of a femur from a shielded limb demonstrating so-called plump osteoblasts in contrast to the more
ﬂattened cells seen elsewhere in the shielded limb (B) or during homeostasis (C). (E) Comparison of the magnitude of osteoblast proliferation, scored according to the
proliferation index (see Methods) among femora from nonirradiated mice (controls), shielded limbs from irradiated mice, and irradiated limbs. Data were analyzed
using a 1-way analysis of variance with Tukey’s multiple comparison test comparing each experimental group with the controls. The bars represent mean  standard
deviation.
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available for donor cell engraftment [30], we would argue
that the transplanted cells were distributed equally
throughout the host marrow space: in the irradiated, ablated
hematopoietic marrowwithmost niches unoccupied and the
shielded, intact hematopoietic marrow with homeostatic
w1% of the niches unoccupied. This interpretation implies
that not only osteoblast expansion, which was observed in
the shielded limb (Figure 5E), but other components of niche
remodeling, including the morphologic changes of osteo-
blasts (Figure 5D) andmegakaryocyte migration [13,21], may
also effectively contribute to HSC engraftment. Moreover,
ablation of a fraction of the host marrow may elicit the
release of circulating factors that foster engraftment of
transplanted donor HSCs throughout the marrow space.
Thus, partial marrow radioablation may facilitate early
engraftment of the transplanted donor HSCs, although direct
ablation of the engrafting sites is not required. Finally, we
cannot infer from our data whether the transplanted HSCs
displaced host HSCs, although this outcome is thought to be
highly unlikely [30].
The leg-shielding studies provided further biologic insight
into HSC engraftment. In the shielded leg of the 6-hourinfusion cohort, the chimerism of HSCs (deﬁned as SLAM
cells) was 20%, whereas that of the hematopoietic progenitor
(KLS) cells was only 3% and that of the total marrow, 10%. A
similar quantitative relationshipwas observed in the 24-hour
cohort. These data indicate that not all donor HSCs engrafting
in the shieldedmarrow space gave rise to hematopoietic cells
early after engraftment, possibly because the microenviron-
mental cues needed to stimulate HSC proliferation and
differentiation were lacking in the relatively well-populated
nonirradiated marrow space. Indeed, when mice were
assessed at 3 weeks post-transplantation, the relative
magnitude of HSC chimerism more closely paralleled the
osteopoietic chimerism rather than the hematopoietic
progenitor or total marrow chimerism, which is reﬂected by
blood chimerism. This may be due to a dual hema-
topoieticeosteopoietic differentiation capacity of the HSC
early after BMT so that osteopoietic chimerism is derived
from the HSC [5,6,10,12,31]. Hence, in murine models,
osteopoietic engraftment assessed early after BMT (e.g., 2 to
3 weeks) may provide a more reliable index of HSC engraft-
ment than does peripheral blood chimerism.
Another observation of interest is that the number
of engrafted donor HSCs increased in the shielded leg
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marrow chimerism in the irradiated leg of mice infused at 24
versus 6 hours postirradiation. Because HSCs are known to
migrate to different areas of the bone marrow space [32,33],
we suggest that some of the HSCs in the shielded leg had
time tomigrate to the ablated leg during the 24-hour interval
between TBI and marrow cell infusion where they began to
proliferate and repopulated the ablated marrow with host
(GFP-) cells. Thus, the engrafted donor cells accounted for
a smaller percentage (reduced chimerism) of the repopu-
lated marrow space.
In shielded legs, the osteoblast proliferation, albeit low, was
greater than in negative controls, with some osteoblasts
demonstrating a plumpmorphology (Figure 5D) similar to that
commonly observed after radioablation [13]. Thismorphologic
change alters the biomechanical properties of the osteoblast
governing adhesion, which may foster greater HSC engraft-
ment than would be predicted from the osteoblast prolifera-
tion alone [34]. These observations suggest novel cross-talk in
the osteoblastic niche, instigatedwhen niche disruption by TBI
signals the absence of occupying HSCs. In response, HSCs from
the shielded leg might egress from their marrow niches into
the circulation and home to available niches in the irradiated
leg. This engraftment would be expected to quench niche
signaling, thereby ending HSC migration. This notion gains
support from our previous observation that the osteoblastic
niche expansion seen after radioablation is readily reversed by
primitive hematopoietic cell engraftment [13,18] and our
current data showing that osteopoietic engraftment is
decreased if small cell doses are transplanted on successive
days, possibly due to down-regulation of the engrafting niches
recognized by osteoprogenitors.
Finally, our data suggest a novel strategy of reduced-
intensity marrow conditioning. With adequate immune
suppression to prevent rejection (which was not a limiting
factor in our studies because of the use of syngeneic inbred
strains of mice), one could deliver ablative agents to selected
nonvital structures such as the limbs and peripheral pelvis to
achieve greater total donor cell engraftment than is
commonly attained. Once engrafted, the donor cells would
differentiate and expand to occupy the entire marrow space
[32]. Our future efforts will be directed toward developing
optimal transplantation strategies for both hematopoietic
and osteopoietic engraftment. We anticipate that the
microenvironmental changes we previously identiﬁed [13]
will play a pivotal role in understanding the mechanisms of
stem cell engraftment and osteopoietic differentiation and
thus in successfully meeting this challenge.
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